Sonoma Pharmaceuticals (SNOA) Capital Expenditures (QoQ) (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -93.10% |
| Mar 31, 2026 | -38.30% |
| Dec 31, 2025 | 370.00% |
| Sep 30, 2025 | -90.57% |
| Jun 30, 2025 | 125.53% |
| Mar 31, 2025 | 2,250.00% |
| Dec 31, 2024 | -92.31% |
| Sep 30, 2024 | 420.00% |
| Jun 30, 2024 | 127.78% |
| Mar 31, 2024 | -1,900.00% |
| Dec 31, 2023 | -50.00% |
| Sep 30, 2023 | -88.24% |
| Jun 30, 2023 | -91.05% |
| Mar 31, 2023 | 512.90% |
| Dec 31, 2022 | 24.00% |
| Sep 30, 2022 | 8.70% |
| Jun 30, 2022 | -62.90% |
| Mar 31, 2022 | 6,100.00% |
| Dec 31, 2021 | -96.00% |
| Sep 30, 2021 | -48.98% |